EFM
SWTX

E Fund Management’s SpringWorks Therapeutics SWTX Stock Holding History

E Fund Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$596K Buy
12,693
+2,326
+22% +$103K 0.03% 210
2025
Q1 		$457K Buy
10,367
+1,629
+19% +$75K 0.02% 238
2024
Q4 		$316K Sell
8,738
-135
-2% -$4.72K 0.02% 306
2024
Q3 		$284K Sell
8,873
-594
-6% -$22.2K 0.01% 267
2024
Q2 		$357K Buy
9,467
+981
+12% +$41.3K 0.02% 210
2024
Q1 		$418K Buy
8,486
+734
+9% +$33.9K 0.03% 203
2023
Q4 		$283K Sell
7,752
-1,474
-16% -$38.5K 0.02% 239
2023
Q3 		$213K Sell
9,226
-3,724
-29% -$102K 0.02% 247
2023
Q2 		$340K Buy
12,950
+528
+4% +$13.9K 0.03% 202
2023
Q1 		$320K Sell
12,422
-4,283
-26% -$125K 0.02% 214
2022
Q4 		$434K Sell
16,705
-98
-0.6% -$2.42K 0.04% 163
2022
Q3 		$479K Sell
16,803
-3,228
-16% -$92.5K 0.04% 130
2022
Q2 		$493K Buy
20,031
+15,474
+340% +$566K 0.04% 143
2022
Q1 		$257K Buy
+4,557
New +$261K 0.01% 252

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

E Fund Management's SWTX Position: Q2 2025 in Review

E Fund Management increased its SpringWorks Therapeutics (SWTX) stake by 22% in Q2 2025, buying an estimated $103K and bringing the position to 12,693 shares worth $596K. The position accounts for 0.03% of the portfolio, ranked #210.

E Fund Management first reported a position in SWTX in Q1 2022 and has held it in 14 quarters since. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • E Fund Management held 12,693 shares of SpringWorks Therapeutics worth $596K as of Q2 2025.
  • E Fund Management bought 2,326 SpringWorks Therapeutics shares in Q2 2025, an estimated $103K.
  • SpringWorks Therapeutics made up 0.03% of E Fund Management's portfolio in Q2 2025, its #210 holding.
  • E Fund Management first reported a position in SpringWorks Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.